Yields higher among patients with a prior advanced adenoma but do not vary significantly with age

Dose-response association seen with higher risk for each additional delirium episode

Benefits include lower carriage, infections, hospitalizations, costs, and deaths

57.1 percent of physicians received payments; median payment was $48, but considerable variation seen in payments

Intervention reduces sitting time at three and six months and yields reduction in systolic blood pressure at six months

Reduction in relapse incidence observed over time, as well as improvement in leukemia-free survival, overall survival

Inappropriate diagnosis common, especially in older patients and those with dementia, altered mental status on presentation

Increase seen during pandemic period, following decrease between 1950 and 2019; child mortality continued to drop during pandemic

Second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus single-dose campaign

Video visits less likely among older patients and those without internet access